Laws on licensing and registration of state pharmaceutical representatives

Thursday, January 6, 2022 January 1, 2022, SB 763 came into effect in Oregon, requiring pharmaceutical…

Outlook 2021 Glaucoma Pharmaceutical Market Outlook Analysis by Major Key Players

New Jersey, United States, – The Global Glaucoma Pharmaceuticals Market report is one of the most…

Imrecoxib Market Size, Reach, Forecast to 2029

New Jersey, United States, – The latest report published by Verified Market Reports shows that the…

Pharmaceutical Anti-Counterfeiting Technology Market 2022 by Types, Applications, and Major Key Players – Simons Security Systems, Amgen, Applied DNA Sciences, Acsis, Alien Technology

The Anti-Counterfeit Pharmaceutical Technology Market report is the most important research for those looking for comprehensive…

Pharmaceutical Traceability Market Size, Trends, Forecast to 2029

New Jersey, United States, – the Pharmaceutical traceability market is thoroughly researched in the report, primarily…

Shanghai Fosun Pharmaceutical: APPOINTMENT OF VICE-PRESIDENT (H ACTIONS)

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited accept no…

More regulation to come in pharma world in New York: Executives say it will bring transparency to consumers

January 3, 2022 @ 6:38 am Got a newsroom tip, a press release, a list of…

Comprehensive Rosuvastatin Market Analysis, Share, Study 2022-2027 | Sun Pharmaceutical Industries, Sandoz International GmbH (Novartis), Lupine Hetero Drugs Biocon Cadilla Pharmaceuticals, Aurobindo Pharmaceuticals – Industrial IT

the Rosuvastatin Market, The report is a comprehensive and in-depth analysis of the global market. The…

Constipation Treatment Market Size, Analysis, Forecast to 2029

New Jersey, United States, – The latest report published by Verified Market Research shows that the…

Pharmaceutical players diverge on the NAFDAC plan to reduce imported drugs to 30%

There appears to be growing dissatisfaction among importers and wholesalers of pharmaceuticals over the recent statement…